![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07C 237/06 | (2006.01) |
A61K 31/165 | (2006.01) | ||
C07D 295/182 | (2006.01) |
(11) | Number of the document | 2155663 |
(13) | Kind of document | T |
(96) | European patent application number | 08749449.8 |
Date of filing the European patent application | 2008-05-14 | |
(97) | Date of publication of the European application | 2010-02-24 |
(45) | Date of publication and mention of the grant of the patent | 2017-11-29 |
(46) | Date of publication of the claims translation | 2018-02-12 |
(86) | Number | PCT/EP2008/003848 |
Date | 2008-05-14 |
(87) | Number | WO 2008/151702 |
Date | 2008-12-18 |
(30) | Number | Date | Country code |
07011766 | 2007-06-15 | EP |
(72) |
MELLONI, Piero, IT
RESTIVO, Alessandra, IT
IZZO, Emanuela, IT
FRANCISCONI, Simona, IT
COLOMBO, Elena, IT
SABIDO-DAVID, Cibele, IT
|
(73) |
Newron Pharmaceuticals S.p.A.,
Via Ariosto, 21, 20091 Bresso (MI),
IT
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Pakeisti 2-[2-(fenil)etilamino]alkanamidų dariniai ir jų, kaip natrio ir (arba) kalcio kanalų moduliatorių, panaudojimas |
SUBSTITUTED 2-[2-(PHENYL)ETHYLAMINO]ALKANEAMIDE DERIVATIVES AND THEIR USE AS SODIUM AND/OR CALCIUM CHANNEL MODULATORS |
Payment date | Validity (years) | Amount | |
2025-04-22 | 18 | 347.00 EUR |
2026-05-14 |